Semaglutide
STEP7
Novo Nordisk · Phase 3 · Completed · Enrollment 375
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Placebo (semaglutide) | 9 participants | 0 participants | 13 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.